 |
Sulfadiazine |
|---|---|
| Trade Name | |
| Orphan Indication | For use in combination with pyrimethamine for the treatment of Toxoplasma gondii encephalitis in patients with and without AIDS |
| USA Market Approval | USA |
| USA Designation Date | 1994-03-14 00:00:00 |
| Sponsor | Eon Labs Manufacturing, Inc.;227-15 North Conduit Avenue;Laurelton, New York, 11413 |
